194 related articles for article (PubMed ID: 30617087)
1. Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine.
Fixsen E; Patel J; Selim MA; Kheterpal M
Oncologist; 2019 Mar; 24(3):e103-e105. PubMed ID: 30617087
[TBL] [Abstract][Full Text] [Related]
2. Resolution of pembrolizumab-associated lichenoid dermatitis with a single dose of methotrexate.
Varma A; Friedlander P; De Moll EH; Desman G; Levitt J
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621697
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab.
McCormick BJ; Zieman D; West-Santos C; Phillips MB
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37339826
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Marques-Piubelli ML; Tetzlaff MT; Nagarajan P; Duke TC; Glitza Oliva IC; Ledesma DA; Aung PP; Torres-Cabala CA; Wistuba II; Prieto VG; Nelson KC; Curry JL
J Cutan Pathol; 2020 Oct; 47(10):954-959. PubMed ID: 32394425
[TBL] [Abstract][Full Text] [Related]
5. Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
Martínez-Doménech Á; García-Legaz Martínez M; Magdaleno-Tapial J; Valenzuela-Oñate C; Pérez-Pastor G; Pérez-Ferriols A
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738845
[TBL] [Abstract][Full Text] [Related]
6. Annular lichenoid dermatitis.
Fabroni C; Salvini C; Piana S; Lo Scocco G
Clin Exp Dermatol; 2010 Dec; 35(8):921-3. PubMed ID: 20456388
[No Abstract] [Full Text] [Related]
7. Annular Lichenoid Dermatitis of Youth: A Chronic Case Managed Using Pimecrolimus.
Malachowski SJ; Creasey M; Kinkley N; Heaphy MR
Pediatr Dermatol; 2016 Nov; 33(6):e360-e361. PubMed ID: 27653808
[TBL] [Abstract][Full Text] [Related]
8. Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report.
Esfahani K; Henderson Berg MH; Zargham H; Billick R; Pehr K; Redpath M; Roshdy O; Miller WH
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771890
[TBL] [Abstract][Full Text] [Related]
9. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.
Tetzlaff MT; Nagarajan P; Chon S; Huen A; Diab A; Omar P; Aung PP; Torres-Cabala CA; Mays SR; Prieto VG; Curry JL
Am J Dermatopathol; 2017 Feb; 39(2):121-129. PubMed ID: 28134729
[TBL] [Abstract][Full Text] [Related]
10. PD1 inhibitor induced inverse lichenoid eruption: a case series.
Sethi M; Garg V; Lee JB; Yang S
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423421
[TBL] [Abstract][Full Text] [Related]
11. Lichen amyloidosus associated with Kimura's disease: successful treatment with cyclosporine.
Teraki Y; Katsuta M; Shiohara T
Dermatology; 2002; 204(2):133-5. PubMed ID: 11937739
[TBL] [Abstract][Full Text] [Related]
12. Annular lichenoid dermatitis of youth: report on two adult cases and one child.
Mahmoudi H; Ghanadan A; Fahim S; Moghanlou S; Etesami I; Daneshpazhooh M
J Dtsch Dermatol Ges; 2019 Nov; 17(11):1173-1176. PubMed ID: 31765090
[No Abstract] [Full Text] [Related]
13. Steroid-Refractory Lichenoid Eruption Associated with Pembrolizumab in a Patient with Non-Small Cell Lung Cancer.
Kou L; Agarwal S; Miceli A; Kolb L; Krishnamurthy K; Schmieder S
HCA Healthc J Med; 2021; 2(6):397-400. PubMed ID: 37427397
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study.
Min Lee CK; Li S; Tran DC; Zhu GA; Kim J; Kwong BY; Chang ALS
J Am Acad Dermatol; 2018 Dec; 79(6):1047-1052. PubMed ID: 29857011
[TBL] [Abstract][Full Text] [Related]
15. Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A.
Werner AH
J Am Vet Med Assoc; 2003 Oct; 223(7):1013-6, 986. PubMed ID: 14552491
[TBL] [Abstract][Full Text] [Related]
16. Lichenoid and granulomatous dermatitis.
Magro CM; Crowson AN
Int J Dermatol; 2000 Feb; 39(2):126-33. PubMed ID: 10692062
[TBL] [Abstract][Full Text] [Related]
17. Oral lichenoid reaction showing multiple ulcers associated with anti-programmed death cell receptor-1 treatment: A report of two cases and published work review.
Obara K; Masuzawa M; Amoh Y
J Dermatol; 2018 May; 45(5):587-591. PubMed ID: 29352490
[TBL] [Abstract][Full Text] [Related]
18. Annular lichenoid dermatitis of youth-Recurrent case of rare skin disease treated with cyclosporine.
Stojkovic-Filipovic J; Lekic B; Brasanac D; Lalosevic J; Gajic-Veljic M; Nikolic M
Dermatol Ther; 2020 May; 33(3):e13285. PubMed ID: 32105384
[TBL] [Abstract][Full Text] [Related]
19. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features.
Tetzlaff MT; Tang S; Duke T; Grabell DA; Cabanillas ME; Zuo Z; Yao JC; Nagarajan P; Aung PP; Torres-Cabala CA; Duvic M; Prieto VG; Huen A; Curry JL
J Cutan Pathol; 2019 Nov; 46(11):872-877. PubMed ID: 31254410
[TBL] [Abstract][Full Text] [Related]
20. Refractory sclerosing panniculitis successfully treated with cyclosporin.
Park MY; Kim JM; Kim GW; Kim HS; Ko HC; Kim MB; Kim BS
J Dermatol; 2016 Nov; 43(11):1374-1376. PubMed ID: 27076085
[No Abstract] [Full Text] [Related]
[Next] [New Search]
